Back to Search Start Over

A practical dynamic nomogram model for predicting bone metastasis in patients with thyroid cancer.

Authors :
Liu WC
Li MP
Hong WY
Zhong YX
Sun BL
Huang SH
Liu ZL
Liu JM
Source :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Mar 06; Vol. 14, pp. 1142796. Date of Electronic Publication: 2023 Mar 06 (Print Publication: 2023).
Publication Year :
2023

Abstract

Purpose: The aim of this study was to established a dynamic nomogram for assessing the risk of bone metastasis in patients with thyroid cancer (TC) and assist physicians to make accurate clinical decisions.<br />Methods: The clinical data of patients with TC admitted to the First Affiliated hospital of Nanchang University from January 2006 to November 2016 were included in this study. Demographic and clinicopathological parameters of all patients at primary diagnosis were analyzed. Univariate and multivariate logistic regression analysis was applied to build a predictive model incorporating parameters. The discrimination, calibration, and clinical usefulness of the nomogram were evaluated using the C-index, ROC curve, calibration plot, and decision curve analysis. Internal validation was evaluated using the bootstrapping method.<br />Results: A total of 565 patients were enrolled in this study, of whom 25 (4.21%) developed bone metastases. Based on logistic regression analysis, age (OR=1.040, P =0.019), hemoglobin (HB) (OR=0.947, P <0.001) and alkaline phosphatase (ALP) (OR=1.006, P =0.002) levels were used to construct the nomogram. The model exhibited good discrimination, with a C-index of 0.825 and good calibration. A C-index value of 0.815 was achieved on interval validation analysis. Decision curve analysis showed that the nomogram was clinically useful when intervention was decided at a bone metastases possibility threshold of 1%.<br />Conclusions: This dynamic nomogram, with relatively good accuracy, incorporating age, HB, and ALP, could be conveniently used to facilitate the prediction of bone metastasis risk in patients with TC.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Liu, Li, Hong, Zhong, Sun, Huang, Liu and Liu.)

Details

Language :
English
ISSN :
1664-2392
Volume :
14
Database :
MEDLINE
Journal :
Frontiers in endocrinology
Publication Type :
Academic Journal
Accession number :
36950687
Full Text :
https://doi.org/10.3389/fendo.2023.1142796